Medicare Enrolled

Dr. Zulekha Atif

Endocrinology · Westfield, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
525 CENTRAL AVE STE D, Westfield, NJ 07090
9083891910
In practice since 2015 (11 years)
NPI: 1427437847 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atif? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Atif

Dr. Zulekha Atif is an endocrinology specialist in Westfield, NJ, with 11 years of NPI registration. Based on federal Medicare data, Dr. Atif performed 484 Medicare services across 318 unique beneficiaries.

Between the years covered by Open Payments, Dr. Atif received a total of $2,098 from 33 pharmaceutical and/or device companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Atif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 484 Medicare services $2,098 industry payments

Medicare Practice Summary

Medicare Utilization ↗
484
Medicare services
Bottom 28% in NJ for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
318
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
281 $104 $363
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
69 $126 $551
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
62 $29 $119
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $72 $247
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
21 $89 $364
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,098
Total received (2021-2024)
Avg $524/year across 4 years
Top 48% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
136
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,098 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$900
2023
$953
2022
$193
2021
$51

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$227
Lilly USA, LLC
$98
Xeris Pharmaceuticals, Inc.
$82
Mannkind Corporation
$64
Amneal Pharmaceuticals LLC
$61
Insulet Corporation
$47
Radius Health, Inc.
$41
Merck Sharp & Dohme LLC
$39
RECORDATI_RARE_DISEASES_INC.
$34
Corcept Therapeutics
$33
Medtronic, Inc.
$26
CeQur Corporation
$18
Alvogen Inc
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
SANOFI-AVENTIS U.S. LLC
$17
Amgen Inc.
$17
Kyowa Kirin, Inc.
$17
ABBVIE INC.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 45.1% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$532
Lilly USA, LLC
$331
Mannkind Corporation
$138
Xeris Pharmaceuticals, Inc.
$131
Insulet Corporation
$109
Merck Sharp & Dohme LLC
$79
Amneal Pharmaceuticals LLC
$61
Radius Health, Inc.
$55
Alvogen Inc
$54
MannKind Corporation
$50
CeQur Corporation
$49
RECORDATI_RARE_DISEASES_INC.
$49
SANOFI-AVENTIS U.S. LLC
$40
Medtronic, Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Amgen Inc.
$34
Corcept Therapeutics
$33
AbbVie Inc.
$33
Horizon Therapeutics plc
$32
Ipsen Biopharmaceuticals, Inc
$19
Azurity Pharmaceuticals, Inc.
$17
Kyowa Kirin, Inc.
$17
ABBVIE INC.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Amphastar Pharmaceuticals, Inc.
$15
Becton, Dickinson and Company
$15
Dexcom, Inc.
$15
Embecta Corp.
$15
AstraZeneca Pharmaceuticals LP
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Amarin Pharma Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BD Nano 2nd Gen Pen Needle · BELSOMRA · CYCLOSET · CeQur Simplicity · Crysvita · Dexcom G6 Transmitter · EVENITY · FARXIGA · GVOKE HYPOPEN · ISTURISA · JARDIANCE · Kerendia · Korlym · LEQVIO · MAVYRET · MINIMED 780G · MOUNJARO · OMVOH · Omnipod · Ozempic · PIFELTRO · RYBELSUS · Rybelsus · SIGNIFOR LAR · SYNTHROID · Somatuline Depot · TEPEZZA · TERIPARATIDE · TRULICITY · TZIELD · Tymlos · UNITHROID · Vascepa · Wegovy · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Westfield?
Compare endocrinologists in the Westfield area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
508
Per 100K population
88.7
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Atif is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Atif experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Atif performed 281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atif receive payments from pharmaceutical companies?
Yes. Dr. Atif received a total of $2,098 from 33 companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atif's costs compare to other endocrinologists in Westfield?
Dr. Atif's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →